Aegis Capital analyst James Jang initiated coverage with a Buy rating on Yield10 Bioscience Inc (YTEN) today and set a price target of $2. The company’s shares opened today at $0.96.
According to TipRanks.com, Jang is a 1-star analyst with an average return of -1.3% and a 35.4% success rate. Jang covers the Services sector, focusing on stocks such as Eagle Bulk Shipping Inc, Genco Shipping, and DHT Holdings.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Yield10 Bioscience Inc with a $2.50 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $1.77 and a one-year low of $0.68. Currently, Yield10 Bioscience Inc has an average volume of 147.2K.
Based on the recent corporate insider activity of 6 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of YTEN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.
